Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
3.000
+0.010 (0.33%)
At close: Feb 11, 2026, 4:00 PM EST
2.980
-0.020 (-0.67%)
Pre-market: Feb 12, 2026, 5:13 AM EST
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $509.82 million as of February 12, 2026. Its market cap has increased by 57.78% in one year.
Market Cap
509.82M
Enterprise Value
358.38M
1-Year Change
57.78%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $509.82M, a decrease of -80.26%. That is a compound annual growth rate of -49.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 508.12M | 67.04% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Forte Biosciences | 533.87M |
| Ginkgo Bioworks Holdings | 531.42M |
| Tenax Therapeutics | 527.41M |
| Keros Therapeutics | 519.14M |
| Alto Neuroscience | 519.12M |
| Lyell Immunopharma | 517.08M |
| Solid Biosciences | 498.63M |
| Lexeo Therapeutics | 495.58M |